• Home
  • About Us
  • Contact
  • Your Account
  • Subscribe
No Result
View All Result
Monday, January 30, 2023
Alternatives Watch
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In
No Result
View All Result
Alternatives Watch
No Result
View All Result

Alts investing at pensions on the rise even in uncertain times

Susan BarretobySusan Barreto
May 26, 2020
in Investor News, Pensions
Trastuzumab Deruxtecan Shows Efficacy in HER2+ Breast Cancer Brain Mets https://www.onclive.com/conference-coverage/esmo-breast-2020/trastuzumab-deruxtecan-shows-efficacy-in-her2-positive-breast-cancer-brain-mets * focus on the brain metastasis angle

Mike Lawrence/CC BY 2.0/Flickr

ShareTweetShareSendSend

Crisis oriented funds are raising billions each week, and investors are still eager to put money to work in private equity, real assets, infrastructure, hedge funds and niche-credit strategies.

Lately at Alternatives Watch, we have seen TALF funds, distressed debt funds raise capital in a matter of weeks rather than months. Recent examples include Oaktree Capital Management’s $15 billion distressed offering and Apollo’s $1.75 billion dislocated credit strategy — Accord Series III B.

Last month, Alternatives Watch tracked a heady pace in alternative investment fundraising with fund closings and asset raising totaling more than $35 billion in April.

Such numbers indicate that a large push toward new investment strategies is underway as the stock market seemingly has yet to fully price in COVID-19’s long-term effects on global corporations. Going further out on the risk curve may seem counterintuitive at a time when market volatility is rising and uncertainty abounds over when the global economy will ever be back to “normal.”

According to a new report from Cambridge Associates, however, a number of active managers that have been closed to new investors are accepting new capital, allowing pension plans to upgrade certain parts of their portfolio.

“Taking advantage of new strategies and managers that may have been on a ‘bench list’ requires swift action, meaning that plan sponsors and/or their advisor will have already completed the appropriate due diligence (or are able to do so quickly),” wrote Cambridge execs Sona Menon, head of North America, and Alex Pekker, managing director in “Navigating Market Crises: Insights and Recommendations for U.S. Plan Sponsors.”

They said that by rebalancing portfolios, investors are able to add strategies and managers that may have been previously unattractive such as distressed credit, certain mortgage strategies and closed-end bond fund strategies that may now fit in the growth fixed-income portion of a portfolio.

Certain long/short hedge fund strategies too may cushion the impact of the equity market downturn and serve as a source of liquidity, the team at Cambridge added.

Following the market slump in March, alternative investment consultant Cliffwater issued its long-term capital assumptions predicting average annualized gains of 16% for venture capital strategies over the next decade, 12.65% for private real estate partnerships and 11.55% for diversified private equity strategies.

Hedge funds, meanwhile, failed to reach average returns above single digits in the consultant’s broad review of investment strategies, while U.S. stocks generally are expected to average 8% returns annually for the next 10 years. The consulting firm uses its capital market assumptions to inform its process for determining asset allocation recommendations.

NEPC surveyed its defined benefit plan clients in March and found that most expected a COVID-19-led recession. A total of 63% of plans surveyed expect a negative return in 2020 for the S&P 500 with 15% expecting losses of more than 10% for the year. A total of 31% said they were rebalancing to target weightings in their portfolios.

“While this is a new landscape of uncertainty, NEPC is counseling corporate pensions and all investors to mitigate risk by staying diversified, rebalancing towards targets, and having a clear plan of action,” said Brad Smith, partner and a member of NEPC’s corporate practice group.

The Boston-based consulting firm said in late April that it had several calls with asset managers to discuss the investment opportunity in the TALF program. In turn, they alerted investors that investment vehicles would likely be set up as shorter-dated drawdown funds, like the fund structures used in private debt, private equity and opportunistic credit.

ShareTweetShareSendSend
Previous Post

Apollo announces $1.75bn close for credit fund

Next Post

Titans set the price on long duration CLOs

Related Posts

Texas fund allocates $90m to private markets, reviews annual plan
Pensions

Texas fund allocates $90m to private markets, reviews annual plan

NJ DOI invests with existing alts managers
Pensions

NJ DOI invests with existing alts managers

Vidrio expands Qontigo partnership with portfolio and risk enhancements
Hedge Funds

Vidrio expands Qontigo partnership with portfolio and risk enhancements

LACERA launches $800m emerging real estate, real asset manager RFPs
Pensions

LACERA launches $800m emerging real estate, real asset manager RFPs

By Rawpixel/Envato Elements
Investor News

Nippon Life to invest $1bn add-on to insurer partnership with Blackstone

Next Post
Titans set the price on long duration CLOs

Titans set the price on long duration CLOs

Log In/Out

Lost your password?

Search the AW Archives

No Result
View All Result

Recent News

Credit deals outpace private equity

Credit deals outpace private equity

Texas fund allocates $90m to private markets, reviews annual plan

Texas fund allocates $90m to private markets, reviews annual plan

Long/short hedge funds struggle as redemptions surge

Long/short hedge funds struggle as redemptions surge

Vision Ridge raises latest sustainable real assets fund

Vision Ridge raises latest sustainable real assets fund

Be an Alts Insider

Sign up for your FREE daily alts news briefing

Subscribe

Subscribe to AW
Alternatives Watch

© 2019-2022, All Rights Reserved  |  BMV Digital

Navigate Site

  • Hedge Funds
  • Private Equity
  • Private Credit
  • RE/Infrastructure
  • Investor News
  • Research
  • Subscribe
  • Log In

Follow Us

No Result
View All Result
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In

© 2019-2022, All Rights Reserved  |  BMV Digital

Be an alts insider

Start your days in the know with our free newsletter

No, I don't want to be an alts insider

Thank

You!

Follow us
on LinkedIn

Lost your password?

Cookie Consent
We do not use cookies on our website other than those that are strictly necessary for the website to function. By clicking “Accept”, you consent to the use of all six strictly necessary cookies.
Do not sell my personal information.
Cookie Settings Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Save & Accept
Powered by CookieYes Logo